Related Experiment Video
Updated: Apr 13, 2026

11:09
Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
Published on: October 23, 2011
16.7K
Establishment and characterization of a genomic DNA reference material for Group B Streptococcus detection
Chengxiang Chu1,2, Zhongqiang Huang3, Xiaoyu Fan3
1Department of Quality Control Material R&D, Shanghai Center for Clinical Laboratory, Shanghai, 200126, China.
Analytical and Bioanalytical Chemistry
|November 19, 2025
Summary
A new Group B Streptococcus (GBS) DNA reference material was developed for accurate molecular detection. This standard revealed inaccuracies in commercial GBS tests, highlighting the need for reliable diagnostic tools.
Area of Science:
- Microbiology
- Molecular Diagnostics
- Biotechnology
Background:
- Group B Streptococcus (GBS) poses significant risks for maternal and neonatal health.
- Accurate GBS detection is crucial for effective clinical management.
- Molecular assays require reliable reference standards for validation.
Purpose of the Study:
- To develop and certify a DNA reference material (RM) for Group B Streptococcus.
- To assess the performance of commercial GBS detection kits using the developed RM.
- To enhance the accuracy and reliability of GBS nucleic acid detection.
Main Methods:
- Genomic DNA extraction from GBS reference strain ATCC® 13813™.
- Quantification of the GBS DNA RM using droplet digital PCR (ddPCR).
- Multi-center collaborative study for RM certification and stability testing.
- Evaluation of commercial GBS detection kits' analytical performance.
Main Results:
- A stable and homogeneous GBS DNA RM was successfully developed.
- The certified value of the RM was determined as (7.53 ± 0.48) × 10³ copies/μL.
- Commercial GBS kits failed to consistently meet their claimed limits of detection.
- Clinical validation confirmed the RM's suitability for diagnostic applications.
Conclusions:
- The developed GBS DNA RM serves as a critical tool for validating molecular diagnostic assays.
- The RM identified performance limitations in commercial GBS detection kits.
- Implementing this RM can improve the accuracy of GBS nucleic acid testing, reducing misdiagnosis and improving patient outcomes.

